Franco Trevisani
Franco Trevisani
Professore di Medicina Interna, Universitą di Bologna
Verified email at
Cited by
Cited by
Sorafenib in advanced hepatocellular carcinoma
JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ...
New England journal of medicine 359 (4), 378-390, 2008
Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials
C Camma, F Schepis, A Orlando, M Albanese, L Shahied, F Trevisani, ...
Radiology 224 (1), 47-54, 2002
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
F Trevisani, PE D'Intino, AM Morselli-Labate, G Mazzella, E Accogli, ...
Journal of hepatology 34 (4), 570-575, 2001
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R Golfieri, E Giampalma, M Renzulli, R Cioni, I Bargellini, C Bartolozzi, ...
British journal of cancer 111 (2), 255-264, 2014
Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma: both or neither?
F Farinati, D Marino, M De Giorgio, A Baldan, M Cantarini, C Cursaro, ...
Official journal of the American College of Gastroenterology| ACG 101 (3 …, 2006
Q‐T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors
M Bernardi, S Calandra, A Colantoni, F Trevisani, ML Raimondo, G Sica, ...
Hepatology 27 (1), 28-34, 1998
Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria
M Ravaioli, GL Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, ...
American Journal of Transplantation 8 (12), 2547-2557, 2008
Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression
M Trudu, S Janas, C Lanzani, H Debaix, C Schaeffer, M Ikehata, L Citterio, ...
Nature medicine 19 (12), 1655-1660, 2013
Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)
F Trevisani, S De Notariis, G Rapaccini, F Farinati, L Benvegnu, M Zoli, ...
Official journal of the American College of Gastroenterology| ACG 97 (3 …, 2002
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
V Santi, F Trevisani, A Gramenzi, A Grignaschi, F Mirici-Cappa, ...
Journal of hepatology 53 (2), 291-297, 2010
Prognosis of untreated hepatocellular carcinoma
EG Giannini, F Farinati, F Ciccarese, A Pecorelli, GL Rapaccini, ...
Hepatology 61 (1), 184-190, 2014
Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal
F Trevisani, M Frigerio, V Santi, A Grignaschi, M Bernardi
Digestive and Liver Disease 42 (5), 341-347, 2010
Cardiac electrophysiological abnormalities in patients with cirrhosis
A Zambruni, F Trevisani, P Caraceni, M Bernardi
Journal of hepatology 44 (5), 994-1002, 2006
Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis
R Golfieri, M Renzulli, V Lucidi, B Corcioni, F Trevisani, L Bolondi
European Radiology 21, 1233-1242, 2011
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ...
Journal of hepatology 62 (3), 617-624, 2015
Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status
G Vendemiale, I Grattagliano, P Caraceni, G Caraccio, M Domenicali, ...
Hepatology 33 (4), 808-815, 2001
Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patient
F Trevisani, PE D'Intino, P Caraceni, M Pizzo, GF Stefanini, A Mazziotti, ...
Cancer 75 (9), 2220-2232, 1995
Longitudinal liquid biopsy and mathematical modeling of clonal evolution forecast time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial
KH Khan, D Cunningham, B Werner, G Vlachogiannis, I Spiteri, T Heide, ...
Cancer discovery 8 (10), 1270-1285, 2018
Recent advances in the natural history of hepatocellular carcinoma
F Trevisani, MC Cantarini, JR Wands, M Bernardi
Carcinogenesis 29 (7), 1299-1305, 2008
Aspartyl‐asparagyl β hydroxylase over‐expression in human hepatoma is linked to activation of insulin‐like growth factor and notch signaling mechanisms
MC Cantarini, SM de la Monte, M Pang, M Tong, A D'Errico, F Trevisani, ...
Hepatology 44 (2), 446-457, 2006
The system can't perform the operation now. Try again later.
Articles 1–20